Failure of insulin-like growth factor 1 to improve radiocontrast nephropathy

Experimental Nephrology

Volumn 5, Issue 1, 1997, Pages 88-94

  Fuchs, S ^a   Yaffe, R ^a   Beeri, R ^a   Rosen, S ^b   Heyman, S N ^a   Brezis, M ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

apoptosis; radiocontrast nephropathy; thick ascending limb; TUNEL

Indexed keywords

CONTRAST MEDIUM; INDOMETACIN; IOTALAMIC ACID; N(G) NITROARGININE; RECOMBINANT SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HENLE LOOP; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOTIN; CONTRAST MEDIA; CREATININE; DEOXYURACIL NUCLEOTIDES; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; HUMANS; INDOMETHACIN; INSULIN-LIKE GROWTH FACTOR I; IOTHALAMIC ACID; KIDNEY FAILURE, ACUTE; MALE; NECROSIS; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RENAL CIRCULATION; STAINING AND LABELING;

EID: 0031052550     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hammerman MR, Miller SB: The growth hormone insulin-like growth factor axis in kidney revisited. Am J Physiol 1993;265:F1-F14.
2. Rotwein P: Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 1991;5:3-18.
3. Zumkeller WZ, Schofield PN: The role of insulin-like growth factors and IGF-binding proteins in the physiological and pathological processes of the kidney. Virchows Arch [B] 1992; 62:207-220.
4. Jaffa AA, LeRoith D, Roberts CT Jr, Rust PF, Mayfield RK: Insulin-like growth factor I produces renal hyperfiltration by a kinin-mediated mechanism. Am J Physiol 1994;266:F102-F107.
5. Hirschberg R, Kopple JD: Evidence that insulin-like growth factor I increases renal blood flow and glomerular filtration rate in fasted rats. J Clin Invest 1989;83:326-330.
6. Hirschberg R, Kopple JD, Blantz RC, Tucker B: Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest 1991;87:1200-1206.
7. Miller BS, Hansen VA, Hammerman MR: Effects of growth hormone and IGF-I on renal function in rats with normal and reduced renal mass. Am J Physiol 1990;259:F747-F751.
8. Guler HP, Eckardt KU, Zapf J, Bauer C, Froesch ER: Insulin-like growth factor 1 increases glomerular nitration rate and renal plasma flow in man. Acta Endocrinol 1989; 121:101-106.
9. Flyvbjerg A, Orskov H, Nyborg K, Frystyk J, Marshall SM, Bornfeld KB, Arnqvist HJ, Jorgensen KD: Kidney IGF-I accumulation occurs in four different conditions with rapid initial kidney growth in rats; in Spencer EM (ed): Modern Concepts of Insulin-Like Growth Factors. Amsterdam, Elsevier Science, 1991, pp 207-217.
10. Guler HP, Zapf J, Scheiwiller E, Froesch ER: Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988;85:4889-4893.
11. Skottner A, Clark RG, Fryklund L, Robinson ICAF: Growth responses in mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. Endocrinology 1989;124:2519-2526.
12. Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, Brinster RL, Palmiter RD: Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 1988;123:2827-2833.
13. Clark R, Mortensen D, Rabkin R: Recovery from acute renal failure is accelerated by des-(1-3)-insulin-like growth factor-I. Clin Sci 1994;86:709-714.
14. Martin AA, Gillespie CM, Moore L, Ballard FJ, Read L: Effects of insulin-like growth factor-I in rats with acute renal failure. J Endocrinol 1994;140:23-32.
15. Ding H, Kopple JD, Cohen A, Hirschberg R: Recombinant human insulin-like growth factor I accelerated recovery and reduced catabolism in rats with ischemic acute renal failure. J Clin Invest 1993;91:2281-2287.
16. Lin JJ, Cybuksky AV, Goodyer PR, Fine RN, Kaskel FJ: Insulin-like growth factor I enhanced growth factor receptor activation and renal tubular cell regeneration in postischemic acute renal failure. J Lab Clin Med 1995;125: 724-733.
17. Noguchi S, Kashihara Y, Ikegami Y, Morimoto K, Miyamoto M, Nakao K: Insulin-like growth factor I ameliorates transient ischemia-induced acute renal failure in rats. J Pharmacol Exp Ther 1993;267:919-926.
18. Verstrepen WA, Nouwen EJ, Yue XS, De Broe ME: Altered growth factor expression during toxic proximal tubular necrosis and regeneration. Kidney Int 1993;43:1267-1279.
19. 2-induced acute renal failure: The effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA. J Am Soc Nephrol 1995; 95:1782-1791.
20. Brezis M, Epstein FH: Pathophysiology of acute renal failure; in Hook BJ, Goldstein JB (eds): Toxicology of the Kidney, ed 2. New York, Raven Press, 1993, pp 129-152.
21. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M: Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994;94:1069-1075.
22. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S: Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidney. J Clin Invest 1991;88:390-395.
23. Heyman SH, Brezis M, Epstein FH, Spoker K, Silva P, Rosen S: Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991;40:632-642.
24. Beeri R, Symon Z, Brezis M, Ben-Sasson SA, Baehr PH, Rosen S, Zager RA: Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 1995;47:1806-1810.
25. Zager RA, Fuerstenberg SM, Baehr PH, Myerson D, Torok-Strob B: An evaluation of antioxidant effects on recovery from postischemic acute renal failure. J Am Soc Nephrol 1994;4: 1588-1597.
26. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Clin Biol 1992;119:493-501.
27. Agmon Y, Brezis M: Effects of nonsteroidal antiinflammatory drugs upon intrarenal blood flow: Selective medullary hypoperfusion. Exp Nephrol 1993;1:357-363.
28. 2 agonists upon intrarenal blood flow. Am J Physiol 1993;265:F802-F806.
29. Brezis M, Agmon Y, Epstein FH: Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol 1994;267:F1059-F1062.
30. Haylor J, Singh I, El Nahas AM: Nitric oxide synthesis inhibitor prevents vasodilation by Insulin-like growth factor I. Kidney Int 1991;39: 333-335.
31. McKillop I, Haylor J, El Nahas AM: IGF-I stimulates renal function in the isolated rat kidney: Inhibition by aminoguanidine and nitroarginine methylester. Exp Nephrol 1995;3: 49-57.
32. Steller H: Apoptosis: Mechanisms and genes of cellular suicide. Science 1995;267:1445-1449.
33. Miller SB, Martin DR, Kissane JM: Growth factors inhibit the apoptotic response to ischemic renal injury in rats. J Am Soc Nephrol 1994;5:904.